Skip to main content
60°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
August 08, 2024
Tags
Business
Eli Lilly and Co
Health & Science
From
CNBC.com News
CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave
August 07, 2024
Tags
Social issues
Health & Science
Business
From
CNBC.com News
Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook
August 07, 2024
Tags
Medicine
Earnings outlook
Health & Science
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Biotech and Pharmaceuticals
Healthy Returns
Abbvie Inc
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Breaking News: Business
US: News
Business News
From
CNBC.com News
Your health records are coming to new apps. Here's why
August 01, 2024
Tags
Health & Science
Internet
Health care industry
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Health & Science
Eli Lilly and Co
Business
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Breaking News: Business
Breaking news
Breaking News: Earnings
From
CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
Tags
Health care industry
Pharmaceuticals
Companies
From
CNBC.com News
23andMe CEO files proposal to take company private as stock craters
July 31, 2024
Tags
US: News
Enterprise
23andMe Holding Co/
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Eli Lilly and Co
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Health care industry
Eisai Co Ltd
Companies
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Companies
Pharmaceuticals
Eisai Co Ltd
From
CNBC.com News
Neuralink rival Synchron lets patients control Apple Vision Pro with their thoughts
July 30, 2024
Tags
Health care industry
Technology
Internet
From
CNBC.com News
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
July 30, 2024
Tags
Business News
Earnings
Biotechnology
From
CNBC.com News
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
July 30, 2024
Tags
Biotech and Pharmaceuticals
US: News
Breaking news
From
CNBC.com News
Dexcom shares plunge more than 40%, head for worst day on record
July 26, 2024
Tags
Health & Science
Business
Technology
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Biotech and Pharmaceuticals
Science
Health & Science
From
CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
Tags
FactSet Research Systems Inc
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
Dexcom shares plummet more than 30% after company lowers fiscal year guidance
July 25, 2024
Tags
Breaking News: Technology
Technology
Health care industry
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Novo Nordisk A/S
Breaking news
Biotech and Pharmaceuticals
From
CNBC.com News
GE HealthCare taps Amazon Web Services to build generative AI for medical use
July 25, 2024
Tags
Media
Hospitals
Health & Science
From
CNBC.com News
India is on alert after a fresh outbreak of the deadly Nipah virus. Here’s what you need to know
July 25, 2024
Tags
Asia News
Pandemics
Asia Politics
From
CNBC.com News
Pfizer's gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
July 24, 2024
Tags
Health care industry
Pharmaceuticals
Companies
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Health & Science
Novartis AG
Johnson & Johnson
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
July 23, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Lawmakers introduce bipartisan bill aiming to crack down on drug middlemen as scrutiny ramps up
July 23, 2024
Tags
CVS Health Corp
Biotechnology
Business News
From
CNBC.com News
Op-ed: How well can AI chatbots mimic doctors in a treatment setting? We put 5 to the test
July 18, 2024
Tags
Breaking News: Technology
Alphabet Inc
Commentary
From
CNBC.com News
A growing number of parents are refusing to give their children smartphones — and the movement is going global
July 17, 2024
Tags
Meta Platforms Inc
Health Tips and Wellness Advice
Business News
From
CNBC.com News
Brain implant patient says OpenAI's tech helps him communicate with family
July 16, 2024
Tags
Enterprise
Tesla Inc
Science
From
CNBC.com News
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.